Aurobindo Pharma shares rise 2.09%; stock among top gainers on Nifty Midcap 150

Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

Shares of Aurobindo Pharma were up 2.09% to Rs 1,072.40 in Monday's session, making it one of the top gainers on the Nifty Midcap 150.

Financial Performance:

Aurobindo Pharma's consolidated financial performance shows consistent growth in revenue and net profit over the years.

Quarterly Performance:

The company's revenue for the quarter-ending June 2025 stood at Rs 7,868.14 Crore, compared to Rs 7,567.02 Crore in June 2024. Net profit for the same period was Rs 822.28 Crore, down from Rs 919.61 Crore in the previous year.

Annual Performance:

The annual revenue for the year-ending March 2025 was Rs 31,723.73 Crore, a significant increase from Rs 29,001.87 Crore in March 2024. The net profit also increased to Rs 3,515.26 Crore in March 2025 from Rs 3,186.13 Crore in March 2024.

The following table summarizes the consolidated quarterly income statement:

Balance Sheet:

The total assets of Aurobindo Pharma as of March 2025 stood at Rs 49,784 Crore, compared to Rs 45,071 Crore in the previous year. The company's reserves and surplus increased to Rs 32,595 Crore from Rs 29,784 Crore during the same period.

Cash Flow:

The net cash flow from operating activities for the year-ending March 2025 was Rs 3,924 Crore, compared to Rs 2,434 Crore in the previous year. The net cash flow for the same period was Rs 2,178 Crore, compared to -Rs 1,006 Crore in the previous year.

Financial Ratios:

Key financial ratios for Aurobindo Pharma show a P/E ratio of 19.40 and a P/B ratio of 2.06 as of March 2025. The company reported a debt-to-equity ratio of 0.24 as of the year-ending March 2025.

Corporate Actions:

Aurobindo Pharma announced an interim dividend of Rs 4.00 per share on August 4, 2025, with an effective date of August 8, 2025. The company has also undergone bonus issues and stock splits in the past.

Aurobindo Pharma Limited has informed the exchange about copy of newspaper publication on August 20, 2025.

Shares of Aurobindo Pharma were trading with very bearish sentiment, according to Moneycontrol analysis.

With the stock's last traded price at Rs 1,072.40, Aurobindo Pharma has shown positive movement, making it a top gainer on the Nifty Midcap 150.